In a recent study, the same group of researchers noted that ED-71 inhibited the growth of squamous cell carcinoma (SCC) cells in vitro and in vivo by down-regulating the expression of HBp17/FGFBP-1, a factor that enhances angiogenesis as well as promotes tumour growth, and FGF-2. Here, FGF2 is linked to squamous cell carcinoma.